Education
About Us
Working with TipRanks
Follow Us
Tyra Bioscience (TYRA)
NASDAQ:TYRA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -519.00K | $ -353.00K | $ -296.00K | $ -140.00K | $ -47.00K |
| Operating Income | $ -104.18M | $ -79.94M | $ -58.93M | $ -26.29M | $ -9.30M |
| EBITDA | $ -85.96M | $ -79.59M | $ -58.63M | $ -26.15M | $ -9.25M |
| Net Income | $ -86.48M | $ -69.13M | $ -51.72M | $ -26.14M | $ -9.31M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 341.44M | $ 203.47M | $ 251.21M | $ 302.18M | $ 15.22M |
| Total Assets | $ 363.56M | $ 225.86M | $ 266.18M | $ 306.70M | $ 16.01M |
| Total Debt | $ 6.22M | $ 6.50M | $ 2.62M | $ 1.18M | $ 142.00K |
| Net Debt | $ -85.74M | $ -51.51M | $ -248.59M | $ -301.00M | $ -15.08M |
| Total Liabilities | $ 20.41M | $ 21.59M | $ 8.35M | $ 4.96M | $ 29.65M |
| Stockholders' Equity | $ 343.15M | $ 204.26M | $ -95.70M | $ 301.74M | $ -13.64M |
| Cash Flow | |||||
| Free Cash Flow | $ -70.44M | $ -50.91M | $ -50.84M | $ -24.41M | $ -8.07M |
| Operating Cash Flow | $ -69.77M | $ -50.14M | $ -50.28M | $ -23.75M | $ -7.76M |
| Investing Cash Flow | $ -98.40M | $ -144.60M | $ -559.00K | $ -645.00K | $ -312.00K |
| Financing Cash Flow | $ 202.14M | $ 1.54M | $ 632.00 | $ 311.35M | $ 23.43M |